期刊文献+

SLE患者血液SC5b-9、ANA及AdsDNA浓度的测定及意义 被引量:9

Determination of SC5b-9,ANA,and AdsDNA antibodies in blood of SLE patients and its significance
下载PDF
导出
摘要 目的:对53例SLE患者血液中的补体末端复合体(C5b-9)、补体溶血总活性(CH50)、抗核抗体(ANA)及抗双链DNA(AdsDNA)抗体的浓度进行了测定。结果:33例活动期SLE患者,其SC5b-9、ANA及AdsDNA的水平均较20例非活动期SLE患者高,CH50活性则较非活动期SLE患者低,活动期与非活动期SLE患者4项指标间的差异均显著(P<001)。此外,用不同方法检测各项指标的敏感性以SC5b-9敏感性最高。结论:患者SC5b-9、AdsDNA、ANA和CH50指标的变化,可为临床正确判断SLE患者的病情活动。 AIM:The contents of terminal complement complex(SC5b-9),complement haemolytic activity(CH 50 ),anti-nuclear antibody(ANA) and anti-double stranded DNA(AdsDNA) in blood of SLE (systemic lupus erythematosus) patients were measured by various methods. RESULTS:The level of SC5b-9, ANA and AdsDNA of active SLE patients were higher than that of inactive SLE patients.But the levels of CH 50 in active SLE patients was lower than that of inactive SLE patients.The differences of the four parameters between active SLE and inactive SLE were significant( P <0 01) The sensitivity of detecting SC56-9 among the four parameters was the highest.CONCLUSION:Changes of SC5b-9,ANA, AdsDNA and CH 50 in the SLE patients could provide scientific basis for diagnosis of active SLE,guiding the use of drugs and evaluating the patient's prognosis.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 1998年第5期525-528,共4页 Chinese Journal of Pathophysiology
关键词 红斑狼疮 补体 抗体 系统性 血清诊断 Lupus erythematosus,systemic Complement Antibodies
  • 相关文献

参考文献5

二级参考文献4

  • 1季晓辉,中华皮肤科杂志,1992年,25卷,281页
  • 2吴中兴,中国血吸虫病防治杂志,1991年,3卷,1期,26页
  • 3吴中兴,中国寄生虫病防治杂志,1989年,2卷,276页
  • 4强能贤,中华皮肤科杂志,1987年,20卷,324页

共引文献2

同被引文献25

  • 1王迎伟,张建民,王晓红.Heymann肾炎(HN)发病机制的实验研究[J].中国免疫学杂志,1993,9(6):368-369. 被引量:4
  • 2彭亮.抗中性粒细胞胞浆抗体与系统性红斑狼疮疾病的关系[J].浙江临床医学,2005,7(8):880-881. 被引量:3
  • 3郭春祥 郭锡琼.介绍一种简单、快速、高效的辣根过氧化物酶标记抗体的过碘酸钠法[J].上海免疫学杂志,1983,3(2):97-100.
  • 4林善琰 卢燕雯.抗中性粒细胞胞浆抗体检测在肾脏疾病诊治中的应用.中国实用内科杂志,2005,7(8):880-880.
  • 5Egner W,Chapel HM.Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitis[J].Clin Exp Immumol,1990,82:244.
  • 6[1]Molnar K,Kovacs L,Kiss M,et al.Antineutrophil cytoplasmic antibodies in patients with systemiclupus erythematosus[J].Clin Exp Dermatol,2002,27(1):59-61.
  • 7[2]Manolov L,Dancheva M,Halacheva K.Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus:prevalence,antigen Specificity,and clinical associations[J].Rheumatol Int,2001,20(5):197-204.
  • 8[3]Chin HJ,Ahn C,Lim CS,et al.Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis[J].Am J Nephrol,2000,20(1):57-63.
  • 9[4]Chikazawa H,NIShiya K,Matsumori A,et al.Immunoglobulin isotypes of antimyeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases[J].J Clin Immunol,2000,20(4):279-286.
  • 10[5]Schnabel A,Cseronk E,lsenberg DA,et al.Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus:Prevalence,speceficities,and clinical significance[J].Arthritis Rheum,1995,38(5):633-637.

引证文献9

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部